Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus

Gerich, 1988, Lilly lecture: glucose counterregulation and its impact on diabetes mellitus, Diabetes, 37, 1608, 10.2337/diab.37.12.1608 Ben-Ami, 1999, Drug-induced hypoglycemic coma in 102 diabetic patients, Arch Intern Med, 159, 281, 10.1001/archinte.159.3.281 McCoy, 2012, Increased mortality of patients with diabetes reporting severe hypoglycemia, Diabetes Care, 35, 1897, 10.2337/dc11-2054 Patrick, 1990, Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes, Diabet Med, 7, 349, 10.1111/j.1464-5491.1990.tb01403.x Shorr, 1997, Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas, Arch Intern Med, 157, 1681, 10.1001/archinte.1997.00440360095010 Wredling, 1990, Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man, Diabetologia, 33, 152, 10.1007/BF00404042 Moen, 2009, Frequency of hypoglycemia and its significance in chronic kidney disease, Clin J Am Soc Nephrol, 4, 1121, 10.2215/CJN.00800209 Weir, 2011, Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study, Nephrol Dial Transplant, 26, 1888, 10.1093/ndt/gfq649 Yun, 2013, Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study, Diabetes Care, 36, 1283, 10.2337/dc12-1408 Pyram, 2012, Chronic kidney disease and diabetes, Maturitas, 71, 94, 10.1016/j.maturitas.2011.11.009 Anavekar, 2004, Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction, N Engl J Med, 351, 1285, 10.1056/NEJMoa041365 Mahmoodi, 2012, Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis, Lancet, 380, 1649, 10.1016/S0140-6736(12)61272-0 Levey, 2012, Chronic kidney disease, Lancet, 379, 165, 10.1016/S0140-6736(11)60178-5 Seaquist, 2013, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society, Diabetes Care, 36, 1384, 10.2337/dc12-2480 2013, Summary of recommendation statements, Kidney Int, 3, 1 Perkins, 2010, In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria, Kidney Int, 77, 57, 10.1038/ki.2009.399 Caramori, 2003, Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions, Diabetes, 52, 1036, 10.2337/diabetes.52.4.1036 MacIsaac, 2006, Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?, Diabetes Care, 29, 1560, 10.2337/dc05-1788 Mogensen, 1995, Microalbuminuria and potential confounders: a review and some observations on variability of urinary albumin excretion, Diabetes Care, 18, 572, 10.2337/diacare.18.4.572 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Earley, 2012, Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review, Ann Intern Med, 156, 785, 10.7326/0003-4819-156-11-201203200-00391 Collins, 2013, US Renal Data System 2012 Annual Data Report, Am J Kidney Dis, 61, e1 New, 2007, Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice, Diabet Med, 24, 364, 10.1111/j.1464-5491.2007.02075.x 2013 Gerich, 1991, Hypoglycemia unawareness, Endocr Rev, 12, 356, 10.1210/edrv-12-4-356 Guillod, 2007, Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring?, Diabetes Metab, 33, 360, 10.1016/j.diabet.2007.03.007 Wentholt, 2007, Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations, Diabet Med, 24, 527, 10.1111/j.1464-5491.2007.02107.x Avram, 1984, Uremic hypoglycemia: a preventable life-threatening complication, N Y State J Med, 84, 593 Rutsky, 1978, Spontaneous hypoglycemia in chronic renal failure, Arch Intern Med, 138, 1364, 10.1001/archinte.1978.03630340036013 Mühlhauser, 1991, Severe hypoglycemia in type I diabetic patients with impaired kidney function, Diabetes Care, 14, 344, 10.2337/diacare.14.4.344 Akram, 2006, Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey, J Diabetes Complications, 20, 402, 10.1016/j.jdiacomp.2005.08.005 Amiel, 2008, Hypoglycaemia in Type 2 diabetes, Diabet Med, 25, 245, 10.1111/j.1464-5491.2007.02341.x Gerich, 2000, Hypoglycaemia and counterregulation in type 2 diabetes, Lancet, 356, 1946, 10.1016/S0140-6736(00)03303-1 Leese, 2003, Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use, Diabetes Care, 26, 1176, 10.2337/diacare.26.4.1176 2007, Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration, Diabetologia, 50, 1140, 10.1007/s00125-007-0599-y Zammitt, 2005, Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities, Diabetes Care, 28, 2948, 10.2337/diacare.28.12.2948 Gangji, 2007, A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin, Diabetes Care, 30, 389, 10.2337/dc06-1789 Holman, 2009, Three-year efficacy of complex insulin regimens in type 2 diabetes, N Engl J Med, 361, 1736, 10.1056/NEJMoa0905479 Taylor, 2013, New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity, Clin Ther, 35, A3, 10.1016/j.clinthera.2012.12.012 Rorsman, 2014, ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion, Diabetologia, 57, 1749, 10.1007/s00125-014-3279-8 Cryer, 2013, Mechanisms of hypoglycemia-associated autonomic failure in diabetes, N Engl J Med, 369, 362, 10.1056/NEJMra1215228 Reno, 2013, Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments, Endocrinol Metab Clin North Am, 42, 15, 10.1016/j.ecl.2012.11.005 Bolli, 1984, J Clin Invest, 73, 1532, 10.1172/JCI111359 Woerle, 2003, Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity, Diabetes, 52, 1386, 10.2337/diabetes.52.6.1386 Gerich, 2001, Hypoglycemia, 921 Torffvit, 1997, The association between diabetic nephropathy and autonomic nerve function in type 1 diabetic patients, Scand J Clin Lab Invest, 57, 183, 10.1080/00365519709056387 Cersosimo, 2000, Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans, Diabetes, 49, 1186, 10.2337/diabetes.49.7.1186 Garber, 1974, Hypoglycemia in compensated chronic renal insufficiency: substrate limitation of gluconeogenesis, Diabetes, 23, 982, 10.2337/diab.23.12.982 Mak, 1992, Glucose and insulin metabolism in uremia, Nephron, 61, 377, 10.1159/000186953 DeFronzo, 1978, Glucose intolerance in uremia: quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin, J Clin Invest, 62, 425, 10.1172/JCI109144 O’Toole, 2012, Managing diabetes in dialysis patients, Postgrad Med J, 88, 160, 10.1136/postgradmedj-2011-130354 Mak, 1996, Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia, J Pediatr, 129, 97, 10.1016/S0022-3476(96)70195-6 Borissova, 1993, Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on haemodialysis, Nephrol Dial Transplant, 8, 93, 10.1093/oxfordjournals.ndt.a092282 Kautzky-Willer, 1995, Intravenous calcitriol normalizes insulin sensitivity in uremic patients, Kidney Int, 47, 200, 10.1038/ki.1995.24 Mak, 1992, Intravenous 1,25-dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients, Kidney Int, 41, 1049, 10.1038/ki.1992.159 Nadkarni, 1992, Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy, Nephron, 60, 100, 10.1159/000186712 Bonds, 2010, The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study, BMJ, 340, b4909, 10.1136/bmj.b4909 Ceriello, 2012, Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes, Diabetes, 61, 2993, 10.2337/db12-0224 Zoungas, 2010, Severe hypoglycemia and risks of vascular events and death, N Engl J Med, 363, 1410, 10.1056/NEJMoa1003795 Frier, 2011, Hypoglycemia and cardiovascular risks, Diabetes Care, 34, S132, 10.2337/dc11-s220 Desouza, 2010, Hypoglycemia, diabetes, and cardiovascular events, Diabetes Care, 33, 1389, 10.2337/dc09-2082 Robinson, 2004, Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes, Diabetologia, 47, 312, 10.1007/s00125-003-1292-4 Wright, 2008, Vascular disease and diabetes: is hypoglycaemia an aggravating factor?, Diabetes Metab Res Rev, 24, 353, 10.1002/dmrr.865 2013, 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada, Can J Diabetes, 37, S1 2010 Japanese Society of Nephrology. Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 [in Japanese]. Tokyo, Japan: Tokyo Igakusha; 2012. National evidence based guidelines for blood glucose control in type 2 diabetes. National Health and Medical Research Council website. http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/di19-diabetes-blood-glucose-control.pdf. Accessed November 25, 2013. Zanchi, 2012, Antidiabetic drugs and kidney disease—recommendations of the Swiss Society for Endocrinology and Diabetology, Swiss Med Wkly, 142, w13629 2012, KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update, Am J Kidney Dis, 60, 850, 10.1053/j.ajkd.2012.07.005 US Food and Drug Administration website. Human drug information section. www.fda.gov/Drugs/default.htm. Accessed January 8, 2014. Nathan, 2009, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025 Scheen, 2013, Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease, Expert Opin Drug Metab Toxicol, 9, 529, 10.1517/17425255.2013.777428 Schumacher, 2001, Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment, Eur J Clin Pharmacol, 57, 147, 10.1007/s002280100280 Inoue, 2003, Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure, Clin Nephrol, 60, 90, 10.5414/CNP60090 Snyder, 2004, Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease, Semin Dial, 17, 365, 10.1111/j.0894-0959.2004.17346.x Johansen, 2008, Exenatide may aggravate moderate diabetic renal impairment: a case report, Br J Clin Pharmacol, 66, 568, 10.1111/j.1365-2125.2008.03221.x Weise, 2009, Exenatide associated ischemic renal failure, Diabetes Care, 32, e22, 10.2337/dc08-1309 Jacobsen, 2009, Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide, Br J Clin Pharmacol, 68, 898, 10.1111/j.1365-2125.2009.03536.x US Food and Drug Administration website. Canagliflozin prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204042s000lbl.pdf. Accessed July 17, 2013. European Commission website. Forxiga (dapagliflozin) product information. http://ec.europa.eu/health/documents/community-register/2012/20121112124487/anx_124487_en.pdf. Accessed July 17, 2013. Paisley, 2013, Dapagliflozin: a review on efficacy, clinical effectiveness and safety, Expert Opin Investig Drugs, 22, 131, 10.1517/13543784.2013.740009 Komala, 2013, Sodium glucose cotransporter 2 and the diabetic kidney, Curr Opin Nephrol Hypertens, 22, 113, 10.1097/MNH.0b013e32835a17ae